The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous group of liver diseases characterized by the accumulation of fat in the liver. The heterogeneity of NAFLD is reflected in a clinical and histologic spectrum where some patients develop isolated steatosis of the liver, termed nonalcoholic fatty liver, whereas others develop hepatocyte injury, ballooning, inflammation, and consequent fibrosis, termed nonalcoholic steatohepatitis (NASH). Systemic insulin resistance is a major driver of hepatic steatosis in NAFLD. Lipotoxicity of accumulated lipids along with activation of the innate immune system are major drivers of NASH. Lipid‐induced sublethal and lethal stress culminates in the activation of inflammatory processes, such as the release of proinflammatory extracellular vesicles and cell death. Innate and adaptive immune mechanisms involving macrophages, dendritic cells, and lymphocytes are central drivers of inflammation that recognize damage‐ and pathogen‐associated molecular patterns and contribute to the progression of the inflammatory cascade. While the activation of the innate immune system and the recruitment of proinflammatory monocytes into the liver in NASH are well known, the exact signals that lead to this remain less well defined. Further, the contribution of other immune cell types, such as neutrophils and B cells, is an area of intense research. Many host factors, such as the microbiome and gut–liver axis, modify individual susceptibility to NASH. In this review, we discuss lipotoxicity, inflammation, and the contribution of interorgan crosstalk in NASH pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 1×
“Insulin resistance (IR) and NAFLD are crucially linked(2,11); IR leads to reduced glucose uptake in adipocytes and muscles, and hepatocytes can secrete dipeptidyl peptidase 4, which promotes adipose tissue inflammation and IR.”
BackgroundMolecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism
Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M., Watkins, S. M., & Hotamisligil, G. S. (2008) · Cell · doi:10.1016/j.cell.2008.07.048 · Cited by 1,139
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 13×
“Recent evidence indicates that immunologic imbalances in the liver support the maintenance and progression of inflammation in NAFLD.”
BackgroundInfluentialHagström, H., Nasr, P., Ekstedt, M., Hammar, U., Stål, P., Hultcrantz, R., & Kechagias, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.027 · Cited by 1,067
Winer, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M. G., Alonso, M. N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2353 · Cited by 1,050
Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., & Suzuki, A. (2019) · Hepatology · doi:10.1002/hep.30626 · Cited by 1,050
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · cited 1×
“Diminished adipose tissue expandability and not obesity itself is believed to be the key factor linking positive energy balance and metabolic disease.(90) Increased influx of adipose tissue-derived NEFAs is a substantial source of substrate for the formation and storage of TGs in the liver, resulting in steatosis.”
BackgroundActivation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 722
Self-citationRivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Volmer, R., van der Ploeg, K., & Ron, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217611110 · Cited by 650
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., et al. (2018) · Hepatology · doi:10.1002/hep.29544 · Cited by 557
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.018 · Cited by 548
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
Self-citationTsurusaki, S., Tsuchiya, Y., Koumura, T., Nakasone, M., Sakamoto, T., Matsuoka, M., Imai, H., Yuet-Yin Kok, C., Okochi, H., Nakano, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1678-y · Cited by 529
Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Wree, A., McGeough, M. D., Peña, C. A., Schlattjan, M., Li, H., Inzaugarat, M. E., Messer, K., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1170-1 · Cited by 486
van der Windt, D. J., Sud, V., Zhang, H., Varley, P. R., Goswami, J., Yazdani, H. O., Tohme, S., Loughran, P., O'Doherty, R. M., Minervini, M. I., et al. (2018) · Hepatology · doi:10.1002/hep.29914 · Cited by 477
Microbiota-induced obesity requires farnesoid X receptor
Parséus, A., Sommer, N., Sommer, F., Caesar, R., Molinaro, A., Ståhlman, M., Greiner, T. U., Perkins, R., & Bäckhed, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310283 · Cited by 474
Xu, B., Jiang, M., Chu, Y., Wang, W., Chen, D., Li, X., Zhang, Z., Zhang, D., Fan, D., Nie, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.040 · Cited by 426
Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Haas, J. T., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 394
Yu, Y., Liu, Y., An, W., Song, J., Zhang, Y., & Zhao, X. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121842 · Cited by 383
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
Ter Horst, K., & Serlie, M. (2017) · Nutrients · doi:10.3390/nu9090981 · Cited by 365
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.031 · Cited by 332
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 325
A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitis
Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D. V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A. T., Bartneck, M., Neumann, U. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403856 · Cited by 314
Ma, Y., Belyaeva, O. V., Brown, P. M., Fujita, K., Valles, K., Karki, S., de Boer, Y. S., Koh, C., Chen, Y., Du, X., et al. (2019) · Hepatology · doi:10.1002/hep.30350 · Cited by 312
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Ghorpade, D. S., Ozcan, L., Zheng, Z., Nicoloro, S. M., Shen, Y., Chen, E., Blüher, M., Czech, M. P., & Tabas, I. (2018) · Nature · doi:10.1038/nature26138 · Cited by 292
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
Luther, J., Garber, J. J., Khalili, H., Dave, M., Bale, S. S., Jindal, R., Motola, D. L., Luther, S., Bohr, S., Jeoung, S. W., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.001 · Cited by 286
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
BasuRay, S., Wang, Y., Smagris, E., Cohen, J. C., & Hobbs, H. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901974116 · Cited by 284
Kakazu, E., Mauer, A. S., Yin, M., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063412 · Cited by 280
Self-citationIbrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Povero, D., Eguchi, A., Li, H., Johnson, C. D., Papouchado, B. G., Wree, A., Messer, K., & Feldstein, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113651 · Cited by 272
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
Ioannou, G. N., Haigh, W. G., Thorning, D., & Savard, C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034876 · Cited by 253
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis
Akazawa, Y., Cazanave, S., Mott, J. L., Elmi, N., Bronk, S. F., Kohno, S., Charlton, M. R., & Gores, G. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.003 · Cited by 252
Inflammasome-mediated regulation of hepatic stellate cells
Watanabe, A., Sohail, M. A., Gomes, D. A., Hashmi, A., Nagata, J., Sutterwala, F. S., Mahmood, S., Jhandier, M. N., Shi, Y., Flavell, R. A., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90223.2008 · Cited by 233
Pillarisetty, V. G., Shah, A. B., Miller, G., Bleier, J. I., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1009 · Cited by 232
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis
Kakisaka, K., Cazanave, S. C., Fingas, C. D., Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Mott, J. L., & Gores, G. J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00301.2011 · Cited by 222
Fas/CD95-Induced Chemokines Can Serve as “Find-Me” Signals for Apoptotic Cells
Cullen, S. P., Henry, C. M., Kearney, C. J., Logue, S. E., Feoktistova, M., Tynan, G. A., Lavelle, E. C., Leverkus, M., & Martin, S. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.025 · Cited by 222
Krenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D. P. P., Mossanen, J. C., Luedde, T., Trautwein, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318382 · Cited by 220
Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., de Mollerat du Jeu, X., Mulya, A., Berk, M., Lazic, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 207
Loomba, R., Quehenberger, O., Armando, A., & Dennis, E. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p055640 · Cited by 197
Hoang, S. A., Oseini, A., Feaver, R. E., Cole, B. K., Asgharpour, A., Vincent, R., Siddiqui, M., Lawson, M. J., Day, N. C., Taylor, J. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48746-5 · Cited by 192
JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kahraman, A., Garrison, S. P., Zambetti, G. P., Charlton, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022491 · Cited by 191
Type I Interferon Responses Drive Intrahepatic T Cells to Promote Metabolic Syndrome
Ghazarian, M., Revelo, X. S., Nøhr, M. K., Luck, H., Zeng, K., Lei, H., Tsai, S., Schroer, S. A., Park, Y. J., Chng, M. H. Y., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7616 · Cited by 190
Self-citationTranscriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis
Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704391200 · Cited by 190
Self-citationCHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis
Cazanave, S. C., Elmi, N. A., Akazawa, Y., Bronk, S. F., Mott, J. L., & Gores, G. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2010 · Cited by 189
Clinical relevance of the bile acid receptor TGR5 in metabolism
van Nierop, F. S., Scheltema, M. J. V., Eggink, H. M., Pols, T. W. H., Sonne, D. P., Knop, F. K., & Soeters, M. R. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30155-3 · Cited by 165
Alvarez-Sola, G., Uriarte, I., Latasa, M. U., Fernandez-Barrena, M. G., Urtasun, R., Elizalde, M., Barcena-Varela, M., Jiménez, M., Chang, H. C., Barbero, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312975 · Cited by 164
Hepatic Fatty Acid Trafficking: Multiple Forks in the Road
Mashek, D. G. (2013) · Advances in Nutrition · doi:10.3945/an.113.004648 · Cited by 160
Zhou, Y., Orešič, M., Leivonen, M., Gopalacharyulu, P. V., Hyysalo, J., Arola, J. T., Verrijken, A., Francque, S., Gaal, L. V., Hyötyläinen, T., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.046 · Cited by 157
Reid, D. T., Reyes, J. L., McDonald, B., Vo, T., Reimer, R. A., & Eksteen, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159524 · Cited by 153
Boaru, S. G., Borkham‐Kamphorst, E., Tihaa, L., Haas, U., & Weiskirchen, R. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-49 · Cited by 147
Hepatic natural killer T‐cell and CD8+ T‐cell signatures in mice with nonalcoholic steatohepatitis
Bhattacharjee, J., Kirby, M., Softic, S., Miles, L., Salazar‐Gonzalez, R., Shivakumar, P., & Kohli, R. (2017) · Hepatology Communications · doi:10.1002/hep4.1041 · Cited by 146
Stanton, M. C., Chen, S., Jackson, J. V., Rojas-Triana, A., Kinsley, D., Cui, L., Fine, J. S., Greenfeder, S. A., Bober, L. A., & Jenh, C. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-8 · Cited by 145
Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis
Cazanave, S. C., Mott, J. L., Bronk, S. F., Werneburg, N. W., Fingas, C. D., Meng, X. W., Finnberg, N. K., El‐Deiry, W. S., Kaufmann, S. H., & Gores, G. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280420 · Cited by 141
Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
Pan, J., Ou, Z., Cai, C., Li, P., Gong, J., Ruan, X. Z., & He, K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.08.006 · Cited by 132
Watt, M. J., Barnett, A., Bruce, C. R., Schenk, S., Horowitz, J. F., & Hoy, A. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2649-3 · Cited by 119
Rensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052411 · Cited by 116
Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., & Clària, J. (2013) · The FASEB Journal · doi:10.1096/fj.13-235614 · Cited by 113
Kremer, M., Hines, I. N., Milton, R. J., & Wheeler, M. D. (2006) · Hepatology · doi:10.1002/hep.21221 · Cited by 112
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Kim, O., Jun, W., & Lee, J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000440905 · Cited by 107
Gentilucci, U. V., Carotti, S., Perrone, G., Mazzarelli, C., Galati, G., Muda, A. O., Picardi, A., & Morini, S. (2014) · Liver International · doi:10.1111/liv.12531 · Cited by 106
Interactions between bile salts, gut microbiota, and hepatic innate immunity
Schubert, K. A., Damink, S. W. M. O., von Bergen�, M., & Schaap, F. G. (2017) · Immunological Reviews · doi:10.1111/imr.12579 · Cited by 106
Liver Fibrosis Occurs Through Dysregulation of MyD88-Dependent Innate B-Cell Activity
Thapa, M., Chinnadurai, R., Velazquez, V. M., Tedesco, D., Elrod, E., Han, J., Sharma, P., Ibegbu, C., Gewirtz, A., Anania, F., et al. (2015) · Hepatology · doi:10.1002/hep.27761 · Cited by 101
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess
Idrissova, L., Malhi, H., Werneburg, N. W., LeBrasseur, N. K., Bronk, S. F., Fingas, C. D., Tchkonia, T., Pirtskhalava, T., White, T. A., Stout, M. B., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.033 · Cited by 100
Self-citationHepatic Dysfunction Caused by Consumption of a High-Fat Diet
Soltis, A. R., Kennedy, N. J., Xin, X., Zhou, F., Ficarro, S. B., Yap, Y. S., Matthews, B. J., Lauffenburger, D. A., White, F. M., Marto, J. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.059 · Cited by 100
Toll receptors: an expanding role in our understanding of human disease
Schuster, J. M., & Nelson, P. S. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.6.767 · Cited by 99
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA
Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Masuoka, H. C., Charlton, M., & Gores, G. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014654 · Cited by 93
Ioannou, G. N., Landis, C. S., Jin, G., Haigh, W. G., Farrell, G. C., Kuver, R., Lee, S. P., & Savard, C. E. (2019) · Hepatology Communications · doi:10.1002/hep4.1348 · Cited by 88
The Inflammasome in Liver Injury and Non-Alcoholic Fatty Liver Disease
Mehal, W. Z. (2014) · Digestive Diseases · doi:10.1159/000360495 · Cited by 79
Chang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 75
Genetic and hormonal control of hepatic steatosis in female and male mice
Norheim, F., Hui, S. T. Y., Külahçıoğlu, E., Mehrabian, M., Cantor, R. M., Pan, C., Parks, B. W., & Lusis, A. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071522 · Cited by 74
Ibusuki, R., Uto, H., Arima, S., Mawatari, S., Setoguchi, Y., Iwashita, Y., Hashimoto, S., Maeda, T., Tanoue, S., Kanmura, S., et al. (2013) · Liver International · doi:10.1111/liv.12203 · Cited by 66
Li, J., Liu, H., Mauer, A. S., Lucien, F., Raiter, A. M., Bandla, H., Mounajjed, T., Yin, Z., Glaser, K. J., Yin, M., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1404 · Cited by 63
Self-citationZhang, F., Jiang, W. W., Li, X., Qiu, X. Y., Wu, Z., Chi, Y. J., Cong, X., & Liu, Y. L. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12362 · Cited by 57
Emerging role of extracellular vesicles in liver diseases
Malhi, H. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00183.2019 · Cited by 54
Self-citationInnate immune cells orchestrate the repair of sterile injury in the liver and beyond
Hossain, M., & Kubes, P. (2019) · European Journal of Immunology · doi:10.1002/eji.201847485 · Cited by 53
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
Raselli, T., Hearn, T., Wyss, A., Atrott, K., Peter, A. M., Frey-Wagner, I. M., Spalinger, M. R., Maggio, E. M., Sailer, A. W., Schmitt, J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093229 · Cited by 49
Chen, J., Liang, B., Bian, D., Luo, Y., Yang, J., Li, Z., Zhuang, Z., Zang, S.-F., & Shi, J.-P. (2019) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2019.08.111 · Cited by 46
Mcl-1 Degradation during Hepatocyte Lipoapoptosis
Masuoka, H. C., Mott, J. L., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kaufmann, S. H., & Gores, G. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039545 · Cited by 44
Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis
Santoro, N., Caprio, S., & Feldstein, A. E. (2013) · Clinical Lipidology · doi:10.2217/clp.13.39 · Cited by 32
Degradation of cIAPs contributes to hepatocyte lipoapoptosis
Akazawa, Y., Guicciardi, M. E., Cazanave, S. C., Bronk, S. F., Werneburg, N. W., Kakisaka, K., Nakao, K., & Gores, G. J. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00111.2013 · Cited by 18
Cited by
Tsurusaki, S., Tsuchiya, Y., Koumura, T., Nakasone, M., Sakamoto, T., Matsuoka, M., Imai, H., Yuet-Yin Kok, C., Okochi, H., Nakano, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1678-y · Cited by 529
Govaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4448 · Cited by 479
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W. S., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki-Järvinen, H., & Loomba, R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 293
Therapeutic pipeline in nonalcoholic steatohepatitis
Vuppalanchi, R., Noureddin, M., Alkhouri, N., & Sanyal, A. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00408-y · Cited by 278
Metadata
- Authors
- Parthasarathy, G., Revelo, X., & Malhi, H.
- Venue
- Hepatology Communications
- Published
- 2020-01-14
- Volume
- 4
- Issue
- 4
- Pages
- 478-492
- ISSN
- 2471-254X (ISSN-L)
- OpenAlex
- W2999907367
- Cited by
- 414
- References
- 104
- FWCI
- 39.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.